Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue

Cancer Investigation

Volumn 14, Issue 3, 1996, Pages 202-210

  Kobrinsky, Nathan L ^a,b   Hartfield, Dawn ^a   Horner, Heather ^a   Maksymiuk, Andrew ^a   Minuk, Gerald Y ^a   White, David F ^a   Feldstein, Thomas J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; PARACETAMOL;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DROWSINESS; FATIGUE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING; WEIGHT REDUCTION;

EID: 0029743395     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012140     Document Type: Article

References (28)

1. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS: Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6:511-518, 1993.
2. Prescott LF, Roscoe P, Wright N, Brown SS: Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1(698):519-522, 1971.
3. Clark R, Borirakchanyarat V, Davidson AR, et al: Hepatic damage and death from overdose of paracetamol. Lancet 1(794):66-70, 1973.
4. Corcoran G, Wong B: Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther 238(3):54-61, 1986.
5. Corcoran GB, Mitchell JR, Vaishnav YN, et al: Evidence that acetaminophen and M-hydroxyacetaminophen form a common arylating intermediate N-acetyl-p-benzoquinoneimine. Mol Pharmacol 18(3):536-542, 1980.
6. Prescott LF, Newton RW, Swainson CP, et al: Successful treatment of severe paracetamol overdosage with cysteamine. Lancet 1(858):588-592, 1974.
7. Prescott LF, Park J, Ballantyne A, et al: Treatment of paracetamol (acelaminophen) poisoning with N-acetyl-cysteine. Lancet 2(8035):432-434, 1977.
8. Prescott LF, Illingworth RN, Critchley JA, et al: Intravenous N-acetylcystine: The treatment of choice for paracetamol poisoning. Br Med J 2(6198): 1097-1100, 1979.
9. Feuer G: Hepatic metabolism and carcinogenesis: Its role in hepatoma and adenocarcinoma. Ann NY Acad Sci 534:541-551, 1988.
10. Mekhail-Ishak K, Hudson N, Tsao MS, et al: Implications for therapy of drug-metabolizing enzymes in human colon cancer. Cancer Res 49(17):4866-4869, 1989.
11. Griffith O, Meister A: Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254:7558-7560, 1979.
12. Crook TR, Souhami RL, Whyman GD, et al: Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res 46(10):5035-5038, 1986.
13. Hamilton TC, Winker MA, Louie KG, et al: Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol 34(14):2583-2586, 1985.
14. Russo A, Carmichael J, Friedman N, et al: The roles of intracellular glutathione in antineoplastic chemotherapy. Int J Radiat Oncol Biol Phys 12(8):1347-1354, 1986.
15. Wu GY, Wu CH, Rubin MI: Acetaminophen hepatotoxicity and targeted rescue: A model for specific chemotherapy of hepatocellular carcinoma. Hepatology 5(5):709-713, 1985.
16. Wanamarta AH, van Rijn J, Blank LE, et al: Effect of N-acetylcysteine on the antiproliferative action of x-rays or bleomycin in cultured human lung tumor cells. J Cancer Res Clin Oncol 115(4):340-344, 1989.
17. Tarbell NJ, Rosenblatt M, Amato DA, et al: The effect of N-acetylcysteine inhalation on the tolerance to thoracic radiation in mice. Radiother Oncol 7(1):77-80, 1986.
18. Harrison EF, Fuquay ME, Hunter HL: Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats. Semin Oncol 10(1 Suppl 1):25-28, 1983.
19. Levy L, Vredevoe DL: The effect of W-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity. Semin Oncol 10(1 Suppl 1):7-16, 1983.
20. Rawlins MD, Henderson DB, Hijarb AB. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 1977; 11:283-286.
21. Rumack BH, Augestein WL: In: Principles of Clinical Toxicology, 2nd ed, edited by JD Bricker, New York, Raven Press, 1990, pp 893-908.
22. Peterson RG, Rumack BH: Pharmacokinetics of acetaminophen in children. Pediatrics 62(5 pt 2 Suppl):877-879, 1978.
23. Slattery JT, Koup JF, Levy G: Acetaminophen pharmacokinetics after overdose. Clin Toxicol 18:111-117, 1981.
24. Jonas AF, Vale A: Paracetamol poisoning and the kidney. J Clin Pharmacol Ther 18:5-8, 1993.
25. Prescott LF, Proudfoot AT, Cregeen RJ: Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 284:421-422, 1982.
26. Moller-Hartmann W, Siegers CP: Nephrotoxicity of paracetamol in the rat-Mechanistic and therapeutic aspects. J Appl Toxicol 11:141-146, 1991.
27. Clements JA, Heading RC, Nimmo LF, et al: Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther 24:420-431, 1978.
28. Nimmo J, Heading RC, Tothill P, et al: Pharmacological modification of gastric emptying: Effects of propanteline and metaclopramide on paracetamol absorption. Br Med J 1:587-589, 1973.